NEWS
Congratulations to our chemists succeeded in developing the Baricitinib intermediate series !
Congratulations to our chemists succeeded in developing the Baricitinib intermediate series !
now we can supply the below Baricitinib intermediate with stable production and high quality :
1) Baricitinib API , cas:1187594-09-7;
2) Baricitinib intermediate--4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin; cas: 1187595-88-5;
3) Baricitinib intermediate--1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
cas:1029716-44-6;
4) Baricitinib intermediate--1-Boc-3-(cyanomethylene)azetidine
cas:1153949-11-1;
5) Baricitinib intermediate--2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile
cas:1187595-85-2;
6) Baricitinib intermediate--4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE
cas:941685-27-4;
7) Baricitinib intermediate--2-(azetidin-3-ylidene)acetonitrile (hydrochloride)
cas:1314910-43-4
Copyright(C)2016,Beijing Cooperate Pharmaceutical Co.,Ltd All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice 京ICP備16040401號
| |||||||||||